M&G PLC acquired a new stake in Heartflow, Inc. (NASDAQ:HTFL – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 319,558 shares of the company’s stock, valued at approximately $15,978,000. M&G PLC owned about 0.37% of Heartflow as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in HTFL. GAMMA Investing LLC lifted its stake in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock valued at $32,000 after purchasing an additional 275 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of Heartflow by 844.7% during the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company’s stock worth $40,000 after purchasing an additional 718 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of Heartflow during the 2nd quarter worth about $53,000. Mayport LLC increased its position in shares of Heartflow by 20.0% during the 2nd quarter. Mayport LLC now owns 12,000 shares of the company’s stock worth $352,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Avior Wealth Management LLC increased its position in shares of Heartflow by 16.1% during the 3rd quarter. Avior Wealth Management LLC now owns 14,553 shares of the company’s stock worth $724,000 after purchasing an additional 2,023 shares during the last quarter.
Insider Buying and Selling
In related news, CFO Vikram Verghese sold 29,714 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the transaction, the chief financial officer owned 184,789 shares of the company’s stock, valued at $9,250,537.34. This represents a 13.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 23,933 shares of the firm’s stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the completion of the sale, the insider owned 73,453 shares in the company, valued at approximately $4,040,649.53. This represents a 24.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 347,963 shares of company stock worth $17,210,559. Corporate insiders own 7.70% of the company’s stock.
Heartflow Trading Down 1.5%
Shares of Heartflow stock opened at $55.80 on Wednesday. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $60.56. The company has a 50 day moving average of $51.56 and a 200 day moving average of $34.87.
Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s revenue for the quarter was up 47.7% on a year-over-year basis. On average, research analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities analysts have recently commented on the stock. Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a report on Friday, August 14th. Wells Fargo & Company lifted their target price on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Piper Sandler reiterated an “overweight” rating and issued a $64.00 target price (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. Robert W. Baird set a $45.00 target price on Heartflow in a research report on Friday, August 14th. Finally, Benchmark restated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Heartflow currently has a consensus rating of “Moderate Buy” and a consensus target price of $48.62.
Get Our Latest Stock Report on Heartflow
Heartflow Profile
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Featured Articles
- Five stocks we like better than Heartflow
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
